Myelodysplastic Syndrome (MDS)
Links shared publicly online about this topic.
- 991total visits
Myelodysplastic Syndrome (MDS)
View full resource at fhcrc.org
Tags: Leukemia, Myelodysplastic Syndrome, Disease and Condition, Relationship, disease
Most Recently Shared on July 27, 2010 at 4:19 pm By:
New videos: Watch our experts share info for patients & families battling myelodysplastic syndrome & related diseases http://ow.ly/2hgJY
Genetic Evolution Of Leukemia Mapped
medicalnewstoday.com — “The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some un” View full resource at medicalnewstoday.com
Most Recently Shared on March 16, 2012 at 7:05 am By:
Genetic Evolution Of Leukemia Mapped http://t.co/p4ykxAjF #genetics
Specific Mutations in AML Affect Response to Therapy - ONA
oncologynurseadvisor.com — “Also, bone marrow cells in myelodysplastic syndromes, secondary AML are clonal.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 15, 2012 at 11:30 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Specific mutations in AML affect response to therapy http://t.co/NPSXe4j3 #Leukemia #MyeloidLeukemia #AML
Scientists map genetic evolution of leukemia
labspaces.net — “The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some uncertainty about whether the syndromes actually are cancer.” View full resource at labspaces.net
Most Recently Shared on March 15, 2012 at 9:30 pm By:
Scientists map genetic evolution of leukemia - http://t.co/Bqe4Ry9g
Scientists map genetic evolution of leukemia - National Cancer Institute
cancer.gov — “By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, MD, and Matthew Walter, MD, have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop” View full resource at cancer.gov
Most Recently Shared on March 15, 2012 at 5:49 pm By:
Scientists from @SitemanCenter map genetic evolution of #leukemia http://t.co/0sDCswkD #cancer #research
More Extensive Gene Profiling Urged in AML, MDS : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 14, 2012 at 9:13 pm By:
Bob Finn - Medical News Net Health News
Two studies show the value of genetic profiling for acute myeloid leukemia and myelodysplastic syndrome - http://t.co/vViPVjUT
Oncology Medical Article | Predicting survival of patients with hypocellular myelodysplastic syndrome
mdlinx.com — “Oncology Medical Article: Predicting survival of patients with hypocellular myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on March 13, 2012 at 4:38 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Predicting survival of patients with hypocellular myelodysplastic syndrome: Cancer http://t.co/nGG340FQ #oncology
Mayo Clinic - Minnesota Partnership Awards New Grant to Study Myelodysplastic Syndrome
mayoclinic.org — “Mayo Clinic - Minnesota Partnership Awards New Grant to Study Myelodysplastic Syndrome” View full resource at mayoclinic.org
Most Recently Shared on March 6, 2012 at 9:24 pm By:
Minnesota Partnership Awards New Grant to Study Myelodysplastic Syndrome: Researchers from the University of Min... http://t.co/UXxIAdBA
CME: Performance Improvement Strategies in Myelodysplastic Syndromes (MDS) - OncologySTAT
oncologystat.com — “Free Online Medical CME Course Credits: Performance Improvement Strategies in Myelodysplastic Syndromes (MDS)” View full resource at oncologystat.com
Most Recently Shared on January 12, 2012 at 7:39 pm By:
OncologySTAT Oncology and Health Site
CME: Performance Improvement Strategies in Myelodysplastic Syndromes (MDS) http://t.co/QCyV8QJK
Key Genetic Error Found In Family Of Blood Cancers
medicalnewstoday.com — “Scientists have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes - a group of blood cancers that can progress to a fatal form of leukemia.The researc” View full resource at medicalnewstoday.com
Most Recently Shared on December 29, 2011 at 8:05 am By:
Key Genetic Error Found In Family Of Blood Cancers http://t.co/Z1BwFK7J #genetics
Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS
news-medical.net — “Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.” View full resource at news-medical.net
Most Recently Shared on December 13, 2011 at 7:59 am By:
Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS: Celgene International... http://t.co/99XviFL8
SF3B1 mutations are prevalent in myelodysplastic syndr... [Blood. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on November 22, 2011 at 9:43 pm By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
Splice mutations in RARS. Recently multiple groups have reported on nex class of mutations in MDS affecting... http://t.co/uEmyp3EP
Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes
news-medical.net — “Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that REVLIMID (lenalidomide) has been granted approval by the Swiss agency for Therapeutic Products (Swissmedic) for use in patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality with or without additional cytogenic abnormalities.” View full resource at news-medical.net
Most Recently Shared on November 21, 2011 at 2:21 pm By:
Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes: Celgene International Sàrl, a subsidiar... http://t.co/4UFqrH4K
Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
bloodjournal.hematologylibrary.org — “Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on November 1, 2011 at 12:48 am By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
Our paper on the difficulties on the diagnosis of MDS out in Blood.... http://t.co/7CS2PAMN
Oncology Article | Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
mdlinx.com — “Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on October 3, 2011 at 10:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome: Cancer http://t.co/JQITHxAo #oncology
Treatment of higher-risk myelodysplastic syndrome. [Semin Oncol. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on September 30, 2011 at 4:01 pm By:
G Garcia-Manero Internist, Oncologist, Physician, and Doctor
The paper on the treatment of higher risk MDS out in the Seminars of Oncology... http://t.co/fgKEMt6X
Advertisement
